Medical Devices Startups
5,183 companies tagged Medical Devices, with their investors and founders.
Vera Therapeutics develops medicines targeting autoimmune-driven kidney diseases, with a focus on reducing the need for dialysis or transplant. The company was founded by a physician and operates as a clinical-stage biotech with a patient-centered approach to drug development.
3 investors
Vexev develops automated vascular imaging technology combining custom in-house robotics, machine learning, and high-resolution ultrasound with computational fluid dynamics to support clinical decision-making. The product targets healthcare and clinical settings in the vascular medical imaging category.
3 investors
An R&D-driven biopharmaceutical company that uses AI to develop breakthrough medicines and vaccines focused on immune system disorders across five therapeutic areas.
3 investors
Vir Biotechnology develops treatments for infectious diseases and oncology, leveraging immunology-focused scientific capabilities. The company targets patients with unmet medical needs across these therapeutic areas.
3 investors
Viridian Therapeutics develops treatments for thyroid eye disease, a rare autoimmune condition affecting the eyes and orbit. The company focuses on clinical development and patient support programs in the biotech sector.
3 investors
Virtual Incision develops a miniaturized robotic-assisted surgery (miniRAS) system called MIRA, designed to fit within hospitals' existing infrastructure. The company targets patients, surgeons, and healthcare facilities in the surgical robotics and medical device market.
3 investors
ViTAA offers the AiORTA Suite, a cloud-based platform that uses explainable AI to analyze CT scans and map the strength and weakness of aortic aneurysm tissue. It supports clinicians across the continuum of aortic aneurysm care, from diagnosis and surveillance to pre-operative planning and post-EVAR monitoring.
3 investors
BetteRx is a pharmacy technology company that provides automated compounding systems and software to enable pharmacists to safely and efficiently prepare personalized, customized medications at scale while maintaining FDA compliance.
3 investors
Vital Trace develops biosensors for continuous lactate monitoring (CLM) to support critical care decisions during childbirth, aiming to provide doctors with real-time clinical data for mothers and babies. The company applies its monitoring technology to life-and-death clinical decisions across medical settings, with a focus on maternal and fetal health.
3 investors
Volta develops a hardware and software platform for genomics sample preparation that automates the extraction of biological information. The company serves researchers, laboratories, and healthcare organizations working in genomics, disease control, forensic science, and medicine.
3 investors
Vytala is a foodtech company that develops nutrition solutions to address fat malabsorption and other nutrient deficiencies. The company focuses on clinical nutrition with an emphasis on improving health outcomes through innovative food science.
3 investors
WHILL designs and sells personal electric mobility devices, including power wheelchairs and sidewalk scooters (e.g. Model C2, Model F, Model R, Model S), and operates autonomous mobility services such as at airports. Its products target people who need assistance with personal mobility, sold in Japan through retailers and rental spots.
3 investors
Xeltis is a medtech company developing bioresorbable vascular implants, such as its aXess conduit for hemodialysis access, that are gradually replaced by the patient's own living tissue. Its Restorex supramolecular polymer technology targets vascular applications including dialysis access, arterial bypass surgery, and pulmonary heart valves for patients undergoing vascular surgery.
3 investors
Xenex builds pulsed Xenon UV light disinfection robots that deactivate pathogens missed during manual cleaning, used by hospitals to reduce environmental contamination and healthcare-associated infections. The company sells to hospital infection control programs as part of a device-plus-service offering.
3 investors
Y-Biologics (μμ΄λ°μ΄μ€λ‘μ§μ€) develops antibody-based drugs using its antibody discovery, fully human antibody library, and antibody engineering technologies, working through its own pipeline and partner collaborations. Its programs include next-generation immuno-oncology therapies such as Multi-AbKine, a multi antibody-cytokine fusion aimed at cancers resistant to existing immunotherapies, along with bispecific antibodies, VHH nanobodies, pH-sensitive antibodies, and ADC antibodies.
3 investors
Yemaachi creates a diverse cancer bio-database to develop oncology drugs effective across diverse patient populations. The company develops precision oncology research, diagnostics, and therapeutics with a focus on inclusion for global communities.
3 investors
Zeit Medical develops a wearable headband with AI-powered sensors that detects strokes in real time and automatically alerts emergency services, targeting patients at high risk for stroke who may be asleep or unable to call for help themselves.
3 investors
Zoundream applies artificial intelligence and sound recognition to analyze and translate newborns' cries in real time, identifying needs such as hunger or sleepiness. It also aims to support the identification and diagnosis of potential newborn pathologies and development disorders for parents and families.
3 investors
Healcerion develops compact ultrasound imaging devices that read spatial information with resolution four times higher than conventional ultrasound, enabling high-contrast diagnostic imaging via the SONON X app. The company provides portable ultrasound solutions (SONON 300L and 300C) for point-of-care and mobile diagnostic applications.
3 investors
LPIXEL (γ¨γ«γγ―γ»γ«) is a Japanese company focused on the research, development, and deployment of medical AI products for healthcare fields including prevention, diagnosis, drug discovery, and surgery. It works as an open-innovation hub with partners, addressing challenges such as radiologist workload and rising pharmaceutical R&D costs.
3 investors
ThinkCyte develops diagnostic devices and cellular analysis platforms using imaging flow cytometry and microfluidics technology. The company serves research institutions, clinical laboratories, and biopharmaceutical companies in the life sciences and diagnostic tools sector.
3 investors
Rege Nephro develops regenerative medicine therapies for kidney disease, focusing on nephron progenitor cell research and differentiation from iPS cells. The company aims to commercialize treatments for patients with kidney disorders and reduce reliance on dialysis and transplantation.
3 investors
Allm develops medical ICT products and digital solutions that connect patients, healthcare providers, and nursing care services. It aims to reduce disparities and mismatches in healthcare, targeting the medical and welfare sector.
3 investors
Buzzreach is a Japanese startup that builds SaaS platforms connecting pharmaceutical companies and medical institutions with patients to support clinical trials and post-launch marketing. It promotes a "DRO" (Digital Research Organization) model using patient-matching via electronic medical records, AI-generated trial documents, decentralized clinical trials, and a patient-centric social network called "miilike."
3 investors